About
Diagnostics and Biologics
Areas of Focus
Categories
DiagnosticsBiologics & BiopharmaceuticalSan Diego & Southern California
Team (16)
Bruce F. Mackler, Ph.D, MS
Director
Nielsen BioSciences
team_member
Christoph Wulf, MBA
Vice President, Commercial
Nielsen BioSciences
executive
David E. Thomas, Jr.
Chairman
Nielsen BioSciences
board_chair
David P. Burney, Ph.D, MBA
President and COO
Nielsen BioSciences
executive
Donald Rindell
Director
Nielsen BioSciences
team_member
Gene J. Ostrow
Director
Nielsen BioSciences
team_member
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
931
By Phase
PHASE3: 2PHASE2: 3
By Status
COMPLETED: 7
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05889845Lead Sponsor
Candin for the Treatment of Common Warts
PHASE3Completed
330 participants
Started: Jan 22, 2025 · Completed: Aug 27, 2025
NCT05799456Lead Sponsor
Glycosaminoglycan Scores as Early Detection Biomarkers in Bladder Urothelial Carcinoma
N/ACompleted
106 participants
Started: Oct 1, 2018 · Completed: Feb 28, 2023
NCT02732665Lead Sponsor
Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma
N/ACompleted
50 participants
Started: Jun 30, 2016 · Completed: Feb 28, 2021
NCT02393417Lead Sponsor
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
PHASE2Completed
243 participants
Started: Mar 31, 2015 · Completed: Mar 31, 2018
NCT01757392Lead Sponsor
Candin Safety & Efficacy Study for the Treatment of Warts
PHASE2Completed
39 participants
Started: Sep 30, 2012 · Completed: Dec 31, 2014
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...